Verrumal is a therapeutic for use in warts with a unique combination of
active ingredients. It has been shown that the combined action of
fluorouracil and salicylic acid is of particular advantage in the treatment
Fluorouracil takes effect against the pathologically increased cell growth
Salicylic acid softens and
dissolves the horny material of warts and as a result it promotes
penetration of the active ingredients at the same time. Dimethylsulphoxide
serves as a solubilizer for the active ingredient fluorouracil.
A film-forming solution has been chosen as solvent base to promote
penetration of the active ingredients into the warts.
After application to the skin Verrumal forms a firm whitish film after the
solvent has evaporated.
100 g solution contain: fluorouracil 0.5 g; salicylic acid 10.0 g;
dimethylsulphoxide 8.0 g.
Common warts, flat juvenile warts, plantar warts.
Verrumal should not be used in the lactation period, in pregnant women or in
women in whom pregnancy cannot be reliably excluded.
Furthermore, it should not be used in persons hypersensitive to the
Verrumal should not be used in babies.
Verrumal is not intended for use on large skin areas (skin area larger than
Verrumal may not come into contact with the eyes or mucous membranes.
Occasional burning, particularly after application.
Erosive cutaneous reactions in rare cases.
Marked burning may necessitate
discontinuation of therapy in very isolated cases. Owing to the intensive
softening effect on the horny layer, whitish discoloration and desquamation
of the skin can occur particularly in the vicinity of the warts.
Dosage and employment
Unless otherwise directed by the physician, Verrumal is applied 2 - 3 times
daily to every wart. Verrumal may only be applied to the wart and not to the
surrounding healthy skin.
It is advisable to remove excessive solution from the brush on the neck of
the bottle before painting the warts. Very small warts can be painted using
a wooden tooth-pick etc. instead of the brush for more exact application.
Prior to each renewed application of Verrumal the existing lacquer film
should be removed by stripping.
In warts round or under the nails (periungual or subungual warts) care
should be taken that Verrumal is not applied to the nail bed.
The size of the treated area should not exceed 25 cm2.
During treatment it is recommended to consult the physician at regular
intervals. Empirically it is of advantage in some cases for the physician to
remove the necrotic tissue resulting from treatment with Verrumal.
The average duration of treatment
is 6 weeks.
Treatment should be continued for
a further week or so after successful therapy.
The bottle should be tightly closed after use since the preparation rapidly
evaporates if the bottle is open and the solution can no longer be used
according to instructions. Store at room temperature (15 - 25 °C).
Available package size
Solution: bottle containing 13 ml
Drugs should be kept carefully and out of the reach of children!